Verastem Announces Start of Late-stage Trial for Meso Drug
The company’s president hopes they’ll be filing for FDA approval by the end of the trial.
The company’s president hopes they’ll be filing for FDA approval by the end of the trial.
A clinical trial using PARP inhibitors to treat breast and ovarian cancers actually showed promise in the treatment of some forms of lung cancer